In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus (VRSA) and hetero VRSA (hVRSA) [4]

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 5, 2002, Pages 760-761

  Wootton, M ^a   Howe, R A ^a   Walsh, T R ^b   Bennett, P M ^b   MacGowan, A P ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GEMIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; METICILLIN; MOXIFLOXACIN; NEOMYCIN; NETILMICIN; NITROFURANTOIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TELITHROMYCIN; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONAL VARIATION; CONTROLLED STUDY; CULTURE MEDIUM; FRANCE; IN VITRO STUDY; JAPAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; SWEDEN; UNITED KINGDOM; UNITED STATES; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; PHYSIOLOGY;

ANTI-BACTERIAL AGENTS; HUMANS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 0036848203     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Wootton, M., Howe, R. A., Hillman, R., Walsh, T. R., Bennett, P. M. & MacGowan, A. P. (2000). A modified population analysis profile (PAP) method to detect Staphylococcus aureus with decreased susceptibility to vancomycin in a UK hospital. Journal of Antimicrobial Chemotherapy 47, 399-403.
2. Andrews, J. M. for the British Society for Antimicrobial Chemotherapy. (2001). Determination of minimum inhibitory concentrations. British Society for Antimicrobial Chemotherapy Working Party Report on Antimicrobial Susceptibility Testing. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 29-42.
3. Ferrara, A., Dos Santos, C., Cimbro, M. & Gialdroni Grassi, G. (1997). Effect of different combinations of sparfloxacin, oxacillin and fosfomycin against methicillin-resistant staphylococci. European Journal of Clinical Microbiology and Infectious Diseases 16, 535-7.
4. Wootton, M., Noel, A. R., MacGowan, A. P., Howe, R. A., Walsh, T. R. & Bennett, P. M. (2001). In-vitro activity of BMS2847576 against Staphylococcus aureus strains with various vancomycin susceptibilities. In Program and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2001. Abstract E715, p. 177. American Society for Microbiology, Washington, DC, USA.
5. Low, D. E. & Nadler, H. L. (1997). A review of in-vitro antibacterial activity of quinuprstin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 39, Suppl. A, 53-8.
6. Rybak, M. J., Hershberger, E., Moldovan, T. & Grucz, R. G. (2000). In vitro activities of daptomycin, linezolid and quinupristin-dalfopristin against staphylococci and enterococci including vancomycin-intermediate and -resistant strains. Antimicrobial Agents and Chemotherapy 44, 1062-6.